Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Frost & Sullivan Commends Mobile Heartbeat™ for Standing Out with its Feature-rich Smartphone Application that Serves the Complete Communication Needs of Clinicians

Frost & Sullivan
Posted on: 13 Sep 16

PR Newswire

MOUNTAIN VIEW, Calif., Sept. 13, 2016

MOUNTAIN VIEW, Calif., Sept. 13, 2016 /PRNewswire/ -- Based on its recent analysis of the secure mobile clinical communication market, Frost & Sullivan recognizes Mobile Heartbeat™ with the 2016 North American Frost & Sullivan Entrepreneurial Company of the Year Award. Mobile Heartbeat has successfully established itself as a leading provider of integrated, holistic, and flexible smartphone-based clinical workflow and team communications solutions. Its achievements include a 38% reduction in steps taken, a 50% improvement in Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores, and a 31% shorter clinician response time. This enables more efficient patient turnaround, allowing hospitals to generate more revenue. Improving doctor to nurse communication by making it simple to find the right person immediately provides a clear ROI for hospitals.

Mobile Heartbeat's flagship MH-CURE clinical communications and collaboration smartphone application is based on its Clinical Urgent REsponse (CURE) technology. MH-CURE provides patient care teams with secure, single smartphone access to all clinical communications, pertinent patient information and lab data, improving patient-specific workflow. The solution also offers a real-time clinical team directory that connects all members of a care team located inside and outside the hospital and across multiple facilities.

MH-CURE can be easily integrated with existing clinical IT systems, such as electronic medical records (EMR), critical test results management (CTRM), clinical alerting and notification, scheduling, contact center, paging, and alarm monitoring. As a result, MH-CURE delivers real-time unified communications for caregivers in a single application and at economical price points, providing an open architecture that breaks down communication silos in an organization. "Mobile Heartbeat's solutions can be deployed on-premise as well as in a private cloud, enabling organizations to use the product deployment model that is best suited to their requirements," said Frost & Sullivan Industry Director, Vikrant Gandhi. "All Mobile Heartbeat services are delivered through a highly intuitive user interface that requires minimal end-user training. The company has established a robust ecosystem of strategic technology partners and continues to innovate alongside its partners to present maximum value to customers."

Unlike competing solutions, Mobile Heartbeat's implementations address the fundamental challenge of enabling converged communication. Mobile Heartbeat boasts a range of benefits, including repeatability at scale, security, and product customization. Because of MH-CURE's outstanding product and service features, Hospital Corporation of America (HCA), a leading US healthcare network, chose Mobile Heartbeat's clinical communication solutions to meet its critical communication requirements. This is the largest clinical communications and collaboration deployment in North America, which is a clear testament to MH-CURE's capabilities.

"Mobile Heartbeat does not employ a one-size-fits-all approach for its secure mobile communication solution, as it can easily scale up or down to fit the customer's current needs," noted Vikrant. "A high-quality product, supported by exceptional product customization and support capabilities, it has helped the company emerge as the preferred provider in the North American secure mobile clinical communication market."

Each year, Frost & Sullivan presents the Entrepreneurial Company of the Year Award to the company that has demonstrated excellence in devising a strong growth strategy and robustly implementing it. The recipient has shown strength in terms of innovation in products and technologies, leadership in customer value, and speed in response to market needs. In short, the award looks at the emerging market participants in the industry and recognizes their best practices that are positioned for future growth excellence.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for outstanding achievement in areas such as leadership, technological innovation, customer service, and product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research.

About Mobile Heartbeat™

Mobile Heartbeat™ uses smartphones to improve clinical workflow and provide secure team communications, delivering better patient care at a lower cost. Mobile Heartbeat consolidates clinical communications, including alarms and notifications, pertinent patient information, lab data, texting, voice and photography. Based upon its Clinical Urgent REsponse (CURE) technology, Mobile Heartbeat provides a real-time clinical team directory that efficiently connects all members of a patient's care team inside and outside the hospital as well as across multiple facilities. Eliminating the need for multiple devices, searching for caregivers and hunting for lab data, Mobile Heartbeat provides a highly efficient, patient-specific, clinical team collaboration solution. For more information, visit

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation, and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics, and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:        Gain access to visionary innovation

Chiara Carella
P: +44 (0) 207.343.8314
F: 210.348.1003

Logo -


To view the original version on PR Newswire, visit:

SOURCE Frost & Sullivan

PR Newswire

Last updated on: 13/09/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.